Navigation Links
Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis

elopment of CellCept in autoimmune indications; and our two phase III clinical programs underway with CellCept: lupus nephritis and pemphigus vulgaris.

With respect to the forward-looking statements contained in this news release, we have made numerous assumptions regarding, among other things: our ability to predict the effects of CellCept on patients; our ability to continue our two phase III clinical programs underway with CellCept: lupus nephritis and pemphigus vulgaris; our ability to protect our intellectual property rights and to not infringe on the intellectual property rights of others; our ability to comply with applicable governmental regulations and standards; and our ability to succeed at establishing a successful commercialization program for any of our potential products. Readers are cautioned that the plans, intentions or expectations disclosed in any forward-looking statements and underlying assumptions may not be achieved and that they should not place undue reliance on any forward-looking statement. Actual results or events could differ materially from the plans, intentions, expectations, and assumptions expressed or implied in any forward-looking statements as a result of numerous risks, uncertainties and other factors, including those relating to: difficulties or delays in the progress, timing and results of clinical trials and studies; difficulties or delays in obtaining regulatory approvals; the FDA may determine that the design and planned analysis of our clinical trials do not adequately address the trial objectives in support of our regulatory submission; future sales of CellCept may be less than expected; our future operating results are uncertain and likely to fluctuate; we may not be able to develop and obtain regulatory approval for CellCept in the treatment of autoimmune indications and any future products in our targeted indications; we may not be able to establish marketing and sales capabilities and the costs of launching Cel
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:8/28/2014)... Aug. 28, 2014 Amgen (NASDAQ: ... License Application (BLA) to the U.S. Food and Drug ... of high cholesterol. Evolocumab is an investigational fully human ... (PCSK9), a protein that reduces the liver,s ability to ... the blood. 1 ­ ...
(Date:8/28/2014)... -- Rx Safes, Inc., the manufacturer of fingerprint recognition home ... new war on drugs to reduce prescription drug abuse, ... than 2,500 children a day experiment with prescription drugs ... accessed from unsecured medicine cabinets, closets and drawers.  While law ... Safes will address the new age drug dealer in ...
(Date:8/28/2014)... 28. August 2014 Sequent ... der Patientenrekrutierung für eine IDE-Pivot-Studie („IDE" ... Beurteilung der Sicherheit und Wirksamkeit des ... („WEB") bekanntgegeben. Adam Arthur, MD, Dozent an ... Neurosurgery/Semmes-Murphey Clinic, und Hauptprüfarzt der WEB-IT-Studie, ...
Breaking Medicine Technology:Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 2Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 3Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 4Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 6Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 7Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 9Rx Safes, Inc. Announces New War On Drugs 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3
... ROG; OTCQX: RHHBY) announced plans today to expand its coagulation ... outpatient clinics with the development of a full line of ... is expected to be introduced in the U.S. and Canada ... Roche Diagnostics is the global market leader in ...
... ORLANDO, Fla., Oct. 4, 2011 The benefits of a ... Now, new research has emerged relating to the role gender ... Gender Differences in a Naturalistic Observational Study of Sleep ... the annual Obesity Society meeting in Orlando, Florida this week. ...
Cached Medicine Technology:Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014 2Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 2Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 3
(Date:8/28/2014)... IL (PRWEB) August 28, 2014 ... communication management solutions, will be sponsoring the 2014 ... The annual event allows Presidio leadership to engage ... fiscal year. Specifically, they will be rolling out ... level. , While at the event, ISI will ...
(Date:8/28/2014)... Commercial growers all over the continent are waitlisted ... grow lights, which perform on par with 1000w HPS at ... lighting needs no cooling equipment and does not overheat the ... Factoring in that they never need bulbs changed, the internal ... year. , For many indoor growers, cooler room temperatures also ...
(Date:8/28/2014)... Lake Worth, FL (PRWEB) August 28, 2014 ... Ohio, on July 21, the FDA issued a ... spreading the word about this harmful substance that is readily ... dangerous. , In May, high school senior Logan Stiner died ... an investigation of the substance, leading the FDA to issue ...
(Date:8/28/2014)... 2014 To kick off the fall ... Dimension One Spas retailers across the country are offering ... models. The Hot Tub Tailgate Event is from August ... for more information and to apply early! , As ... a wide variety of outdoor hot tubs with exclusive ...
(Date:8/28/2014)... Ebola vaccine could be given to healthy volunteers in ... September, as part of an series of safety trials ... has killed more than 1,400 people in the current ... candidate vaccine, being co-developed by the US National Institutes ... with funding from an international consortium in response to ...
Breaking Medicine News(10 mins):Health News:ISI Telemanagement Solutions, Inc. to Sponsor 2014 Presidio Exchange 2Health News:New Kind K5 Series LED Grow Lights Pave Way for Future of Indoor Gardening 2Health News:FDA Issues Safety Advisory for Caffeine Powders 2Health News:Ebola vaccine trials fast-tracked by international consortium 2Health News:Ebola vaccine trials fast-tracked by international consortium 3Health News:Ebola vaccine trials fast-tracked by international consortium 4
... for a group of around ten people, as they suffered ... group of students who visited Morningside park in Scarborough, ... Punqudutivu Students Association of Sri Lanka were taken ill with ... Health on Thursday confirmed six cases of E. coli ...
... thin during her performance at Hiro Ballroom on July 12 ... her emaciated appearance. ,The former Hole singer stopped ... then apologized to the crowd, saying that she "had to ... shakes for my anorexia. You're going to have to wait ...
... her shoes at 5 in the morning after a night of ... a party at the Sunset Tower Hotel and looked weary after ... said that Hilton was exhausted after visiting San Francisco for presenting ... star returned to the LA club scene once again, just two ...
... Idaho is helping to increase understanding about normal vaginal ... make women prone to infections and other diseases, ... ,Women suffer from insidious health problems, including bacterial vaginosis ... droves to seek medical treatment, said Larry Forney, a ...
... in dogs may help explain why and how certain ... treatments for both canine and human cancer patients. ... the School of Veterinary Medicine and Science at The ... between certain types of human and canine cancersuch as ...
... has nearly 720 dyeing units, is ranked topmost in ... a study commissioned by the state's pollution watchdog, Tamil ... hazardous waste is generated every year in Tirupur. ... India, discharges nearly 100 million litres of effluent water ...
Cached Medicine News:Health News:Vaginal Bacteria Vary Among Healthy Women 2Health News:Textile City Tirupur in Tamil Nadu Tops in Pollution Generation 2
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: